Harrow Inc., a leading North American eyecare pharmaceutical company, has appointed Mike Biega as Vice President of Investor Relations and Communications. Biega succeeds Jamie Webb, who is retiring, and will remain in her role until August to ensure a smooth transition. Biega brings over a decade of experience in biotech investor relations, having previously served as Sr. Director, Head of Investor Relations at Sensei Biotherapeutics.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harrow Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250618606966) on June 18, 2025, and is solely responsible for the information contained therein.